-
1
-
-
0024955886
-
Approaching the asymptote? Evolution and revolution in immunology.
-
doi: 10.1101/SQB.1989.054.01.003
-
Janeway Jr C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol (1989) 54(Pt 1):1-13. doi: 10.1101/SQB.1989.054.01.003
-
(1989)
Cold Spring Harb Symp Quant Biol
, vol.54
, Issue.PART 1
, pp. 1-13
-
-
Janeway Jr, C.A.1
-
2
-
-
0036212849
-
Innate immune recognition
-
doi:10.1146/annurev.immunol.20.083001.084359
-
Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol (2002) 20:197-216. doi:10.1146/annurev.immunol.20.083001.084359
-
(2002)
Annu Rev Immunol
, vol.20
, pp. 197-216
-
-
Janeway Jr, C.A.1
Medzhitov, R.2
-
3
-
-
77950343791
-
Pattern recognition receptors and inflammation
-
doi:10.1016/j.cell.2010.01.022
-
Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell (2010) 140:805-20. doi:10.1016/j.cell.2010.01.022
-
(2010)
Cell
, vol.140
, pp. 805-820
-
-
Takeuchi, O.1
Akira, S.2
-
4
-
-
0030831210
-
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
-
doi:10.1038/41131
-
Medzhitov R, Preston-Hurlburt P, Janeway Jr C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (1997) 388:394-7. doi:10.1038/41131
-
(1997)
Nature
, vol.388
, pp. 394-397
-
-
Medzhitov, R.1
Preston-Hurlburt, P.2
Janeway Jr, C.A.3
-
5
-
-
0025774776
-
Drosophila toll and IL-1 receptor
-
doi:10.1038/351355b0
-
Gay NJ, Keith FJ. Drosophila toll and IL-1 receptor. Nature (1991) 351:355-6. doi:10.1038/351355b0
-
(1991)
Nature
, vol.351
, pp. 355-356
-
-
Gay, N.J.1
Keith, F.J.2
-
6
-
-
0027931646
-
The product of the tobacco mosaic virus resistance gene N: similarity to toll and the interleukin-1 receptor
-
doi:10.1016/0092-8674(94)90283-6
-
Whitham S, Dinesh-Kumar SP, Choi D, Hehl R, Corr C, Baker B. The product of the tobacco mosaic virus resistance gene N: similarity to toll and the interleukin-1 receptor. Cell (1994) 78:1101-15. doi:10.1016/0092-8674(94)90283-6
-
(1994)
Cell
, vol.78
, pp. 1101-1115
-
-
Whitham, S.1
Dinesh-Kumar, S.P.2
Choi, D.3
Hehl, R.4
Corr, C.5
Baker, B.6
-
7
-
-
3142724031
-
Toll-like receptor signalling
-
doi:10.1038/nri1391
-
Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol (2004) 4:499-511. doi:10.1038/nri1391
-
(2004)
Nat Rev Immunol
, vol.4
, pp. 499-511
-
-
Akira, S.1
Takeda, K.2
-
8
-
-
77249160271
-
Localisation and trafficking of Toll-like receptors: an important mode of regulation
-
doi:10.1016/j.coi.2009.12.002
-
McGettrick AF, O'Neill LA. Localisation and trafficking of Toll-like receptors: an important mode of regulation. Curr Opin Immunol (2010) 22:20-7. doi:10.1016/j.coi.2009.12.002
-
(2010)
Curr Opin Immunol
, vol.22
, pp. 20-27
-
-
McGettrick, A.F.1
O'Neill, L.A.2
-
9
-
-
0024299087
-
The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein
-
doi:10.1016/0092-8674(88)90516-8
-
Hashimoto C, Hudson KL, Anderson KV. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell (1988) 52:269-79. doi:10.1016/0092-8674(88)90516-8
-
(1988)
Cell
, vol.52
, pp. 269-279
-
-
Hashimoto, C.1
Hudson, K.L.2
Anderson, K.V.3
-
10
-
-
0030595339
-
The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults
-
doi:10.1016/S0092-8674(00)80172-5
-
Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell (1996) 86:973-83. doi:10.1016/S0092-8674(00)80172-5
-
(1996)
Cell
, vol.86
, pp. 973-983
-
-
Lemaitre, B.1
Nicolas, E.2
Michaut, L.3
Reichhart, J.M.4
Hoffmann, J.A.5
-
11
-
-
0032509295
-
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene
-
doi:10.1126/science.282.5396.2085
-
Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 282:2085-8. doi:10.1126/science.282.5396.2085
-
(1998)
Science
, vol.282
, pp. 2085-2088
-
-
Poltorak, A.1
He, X.2
Smirnova, I.3
Liu, M.Y.4
Van Huffel, C.5
Du, X.6
-
12
-
-
0012929728
-
Toll-like receptors
-
doi:10.1146/annurev.immunol.21.120601.141126
-
Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol (2003) 21:335-76. doi:10.1146/annurev.immunol.21.120601.141126
-
(2003)
Annu Rev Immunol
, vol.21
, pp. 335-376
-
-
Takeda, K.1
Kaisho, T.2
Akira, S.3
-
13
-
-
0037290876
-
Mammalian Toll-like receptors
-
doi:10.1016/S0952-7915(03)00005-0
-
Akira S. Mammalian Toll-like receptors. Curr Opin Immunol (2003) 15:5-11. doi:10.1016/S0952-7915(03)00005-0
-
(2003)
Curr Opin Immunol
, vol.15
, pp. 5-11
-
-
Akira, S.1
-
14
-
-
43349087755
-
Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling
-
doi:10.1189/jlb.0807586
-
Farhat K, Riekenberg S, Heine H, Debarry J, Lang R, Mages J, et al. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J Leukoc Biol (2008) 83:692-701. doi:10.1189/jlb.0807586
-
(2008)
J Leukoc Biol
, vol.83
, pp. 692-701
-
-
Farhat, K.1
Riekenberg, S.2
Heine, H.3
Debarry, J.4
Lang, R.5
Mages, J.6
-
15
-
-
0037189544
-
Monomeric recombinant MD-2 binds toll-like receptor 4 tightly and confers lipopolysaccharide responsiveness
-
doi:10.1074/jbc.M202554200
-
Re F, Strominger JL. Monomeric recombinant MD-2 binds toll-like receptor 4 tightly and confers lipopolysaccharide responsiveness. J Biol Chem (2002) 277:23427-32. doi:10.1074/jbc.M202554200
-
(2002)
J Biol Chem
, vol.277
, pp. 23427-23432
-
-
Re, F.1
Strominger, J.L.2
-
16
-
-
0036301797
-
Essential role of MD-2 in LPS responsiveness and TLR4 distribution
-
doi:10.1038/ni809
-
Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol (2002) 3:667-72. doi:10.1038/ni809
-
(2002)
Nat Immunol
, vol.3
, pp. 667-672
-
-
Nagai, Y.1
Akashi, S.2
Nagafuku, M.3
Ogata, M.4
Iwakura, Y.5
Akira, S.6
-
17
-
-
77949940198
-
Intracellular toll-like receptors
-
doi:10.1016/j.immuni.2010.03.012
-
Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity (2010) 32:305-15. doi:10.1016/j.immuni.2010.03.012
-
(2010)
Immunity
, vol.32
, pp. 305-315
-
-
Blasius, A.L.1
Beutler, B.2
-
18
-
-
3142683548
-
TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function
-
doi:10.1016/j.immuni.2004.06.007
-
Krug A, French AR, Barchet W, Fischer JA, Dzionek A, Pingel JT, et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity (2004) 21:107-19. doi:10.1016/j.immuni.2004.06.007
-
(2004)
Immunity
, vol.21
, pp. 107-119
-
-
Krug, A.1
French, A.R.2
Barchet, W.3
Fischer, J.A.4
Dzionek, A.5
Pingel, J.T.6
-
19
-
-
0842328805
-
Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9
-
doi:10.1182/blood-2003-08-2674
-
Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood (2004) 103:1433-7. doi:10.1182/blood-2003-08-2674
-
(2004)
Blood
, vol.103
, pp. 1433-1437
-
-
Krug, A.1
Luker, G.D.2
Barchet, W.3
Leib, D.A.4
Akira, S.5
Colonna, M.6
-
20
-
-
1542317550
-
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
-
doi:10.1126/science.1093616
-
Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science (2004) 303:1529-31. doi:10.1126/science.1093616
-
(2004)
Science
, vol.303
, pp. 1529-1531
-
-
Diebold, S.S.1
Kaisho, T.2
Hemmi, H.3
Akira, S.4
Reis e Sousa, C.5
-
21
-
-
12144286763
-
Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection
-
doi:10.1073/pnas.0400525101
-
Tabeta K, Georgel P, Janssen E, Du X, Hoebe K, Crozat K, et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A (2004) 101:3516-21. doi:10.1073/pnas.0400525101
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 3516-3521
-
-
Tabeta, K.1
Georgel, P.2
Janssen, E.3
Du, X.4
Hoebe, K.5
Crozat, K.6
-
22
-
-
31344466165
-
The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9
-
doi:10.1038/ni1297
-
Tabeta K, Hoebe K, Janssen EM, Du X, Georgel P, Crozat K, et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol (2006) 7:156-64. doi:10.1038/ni1297
-
(2006)
Nat Immunol
, vol.7
, pp. 156-164
-
-
Tabeta, K.1
Hoebe, K.2
Janssen, E.M.3
Du, X.4
Georgel, P.5
Crozat, K.6
-
23
-
-
46449093431
-
Molecular mechanisms of phagocytic uptake in mammalian cells
-
doi:10.1007/s00018-008-7578-4
-
Groves E, Dart AE, Covarelli V, Caron E. Molecular mechanisms of phagocytic uptake in mammalian cells. Cell Mol Life Sci (2008) 65:1957-76. doi:10.1007/s00018-008-7578-4
-
(2008)
Cell Mol Life Sci
, vol.65
, pp. 1957-1976
-
-
Groves, E.1
Dart, A.E.2
Covarelli, V.3
Caron, E.4
-
24
-
-
0037422066
-
Regulated portals of entry into the cell
-
doi:10.1038/nature01451
-
Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature (2003) 422:37-44. doi:10.1038/nature01451
-
(2003)
Nature
, vol.422
, pp. 37-44
-
-
Conner, S.D.1
Schmid, S.L.2
-
25
-
-
0742324860
-
TLR signaling pathways
-
doi:10.1016/j.smim.2003.10.003
-
Takeda K, Akira S. TLR signaling pathways. Semin Immunol (2004) 16:3-9. doi:10.1016/j.smim.2003.10.003
-
(2004)
Semin Immunol
, vol.16
, pp. 3-9
-
-
Takeda, K.1
Akira, S.2
-
26
-
-
66649127621
-
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma
-
doi:10.1038/nature07968
-
Compagno M, Lim WK, Grunn A, Nandula SV, Brahmachary M, Shen Q, et al. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature (2009) 459:717-21. doi:10.1038/nature07968
-
(2009)
Nature
, vol.459
, pp. 717-721
-
-
Compagno, M.1
Lim, W.K.2
Grunn, A.3
Nandula, S.V.4
Brahmachary, M.5
Shen, Q.6
-
27
-
-
34250842580
-
Distinct roles of TIR and non-TIR regions in the subcellular localization and signaling properties of MyD88
-
doi:10.1016/j.febslet.2007.06.008
-
Nishiya T, Kajita E, Horinouchi T, Nishimoto A, Miwa S. Distinct roles of TIR and non-TIR regions in the subcellular localization and signaling properties of MyD88. FEBS Lett (2007) 581:3223-9. doi:10.1016/j.febslet.2007.06.008
-
(2007)
FEBS Lett
, vol.581
, pp. 3223-3229
-
-
Nishiya, T.1
Kajita, E.2
Horinouchi, T.3
Nishimoto, A.4
Miwa, S.5
-
28
-
-
0031423761
-
MyD88: an adapter that recruits IRAK to the IL-1 receptor complex
-
doi:10.1016/S1074-7613(00)80402-1
-
Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity (1997) 7:837-47. doi:10.1016/S1074-7613(00)80402-1
-
(1997)
Immunity
, vol.7
, pp. 837-847
-
-
Wesche, H.1
Henzel, W.J.2
Shillinglaw, W.3
Li, S.4
Cao, Z.5
-
29
-
-
84886915828
-
Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells
-
doi:10.1074/jbc.M113.490946
-
Loiarro M, Volpe E, Ruggiero V, Gallo G, Furlan R, Maiorino C, et al. Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells. J Biol Chem (2013) 288:30210-22. doi:10.1074/jbc.M113.490946
-
(2013)
J Biol Chem
, vol.288
, pp. 30210-30222
-
-
Loiarro, M.1
Volpe, E.2
Ruggiero, V.3
Gallo, G.4
Furlan, R.5
Maiorino, C.6
-
30
-
-
77953714711
-
Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling
-
doi:10.1038/nature09121
-
Lin SC, Lo YC, Wu H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature (2010) 465:885-90. doi:10.1038/nature09121
-
(2010)
Nature
, vol.465
, pp. 885-890
-
-
Lin, S.C.1
Lo, Y.C.2
Wu, H.3
-
31
-
-
18444390259
-
Distinct molecular mechanism for initiating TRAF6 signalling
-
doi:10.1038/nature00888
-
Ye H, Arron JR, Lamothe B, Cirilli M, Kobayashi T, Shevde NK, et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature (2002) 418:443-7. doi:10.1038/nature00888
-
(2002)
Nature
, vol.418
, pp. 443-447
-
-
Ye, H.1
Arron, J.R.2
Lamothe, B.3
Cirilli, M.4
Kobayashi, T.5
Shevde, N.K.6
-
32
-
-
69949093459
-
Direct activation of protein kinases by unanchored polyubiquitin chains
-
doi:10.1038/nature08247
-
Xia ZP, Sun L, Chen X, Pineda G, Jiang X, Adhikari A, et al. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature (2009) 461:114-9. doi:10.1038/nature08247
-
(2009)
Nature
, vol.461
, pp. 114-119
-
-
Xia, Z.P.1
Sun, L.2
Chen, X.3
Pineda, G.4
Jiang, X.5
Adhikari, A.6
-
33
-
-
0032217264
-
Structure of an IkappaBalpha/NF-kappaB complex
-
doi:10.1016/S0092-8674(00)81698-0
-
Jacobs MD, Harrison SC. Structure of an IkappaBalpha/NF-kappaB complex. Cell (1998) 95:749-58. doi:10.1016/S0092-8674(00)81698-0
-
(1998)
Cell
, vol.95
, pp. 749-758
-
-
Jacobs, M.D.1
Harrison, S.C.2
-
34
-
-
24644433852
-
Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1)
-
doi:10.1073/pnas.0505997102
-
Li Q, Lu Q, Bottero V, Estepa G, Morrison L, Mercurio F, et al. Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1). Proc Natl Acad Sci U S A (2005) 102:12425-30. doi:10.1073/pnas.0505997102
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 12425-12430
-
-
Li, Q.1
Lu, Q.2
Bottero, V.3
Estepa, G.4
Morrison, L.5
Mercurio, F.6
-
35
-
-
61849127839
-
The IkappaB kinase complex: master regulator of NF-kappaB signaling
-
doi:10.1007/s12026-008-8025-1
-
Solt LA, May MJ. The IkappaB kinase complex: master regulator of NF-kappaB signaling. Immunol Res (2008) 42:3-18. doi:10.1007/s12026-008-8025-1
-
(2008)
Immunol Res
, vol.42
, pp. 3-18
-
-
Solt, L.A.1
May, M.J.2
-
36
-
-
69949185813
-
AP-1 activated by toll-like receptors regulates expression of IL-23 p19
-
doi:10.1074/jbc.M109.025528
-
Liu W, Ouyang X, Yang J, Liu J, Li Q, Gu Y, et al. AP-1 activated by toll-like receptors regulates expression of IL-23 p19. J Biol Chem (2009) 284:24006-16. doi:10.1074/jbc.M109.025528
-
(2009)
J Biol Chem
, vol.284
, pp. 24006-24016
-
-
Liu, W.1
Ouyang, X.2
Yang, J.3
Liu, J.4
Li, Q.5
Gu, Y.6
-
37
-
-
69949183194
-
MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses
-
doi:10.1074/jbc.M109.023044
-
Verstak B, Nagpal K, Bottomley SP, Golenbock DT, Hertzog PJ, Mansell A. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses. J Biol Chem (2009) 284:24192-203. doi:10.1074/jbc.M109.023044
-
(2009)
J Biol Chem
, vol.284
, pp. 24192-241203
-
-
Verstak, B.1
Nagpal, K.2
Bottomley, S.P.3
Golenbock, D.T.4
Hertzog, P.J.5
Mansell, A.6
-
38
-
-
0037153191
-
Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4
-
doi:10.1038/nature01182
-
Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, Kaisho T, et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature (2002) 420:324-9. doi:10.1038/nature01182
-
(2002)
Nature
, vol.420
, pp. 324-329
-
-
Yamamoto, M.1
Sato, S.2
Hemmi, H.3
Sanjo, H.4
Uematsu, S.5
Kaisho, T.6
-
39
-
-
67649865588
-
Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling
-
doi:10.1073/pnas.0812956106
-
Ohnishi H, Tochio H, Kato Z, Orii KE, Li A, Kimura T, et al. Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling. Proc Natl Acad Sci U S A (2009) 106:10260-5. doi:10.1073/pnas.0812956106
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 10260-10265
-
-
Ohnishi, H.1
Tochio, H.2
Kato, Z.3
Orii, K.E.4
Li, A.5
Kimura, T.6
-
40
-
-
80052284504
-
IRF7: activation, regulation, modification and function
-
doi:10.1038/gene.2011.21
-
Ning S, Pagano JS, Barber GN. IRF7: activation, regulation, modification and function. Genes Immun (2011) 12:399-414. doi:10.1038/gene.2011.21
-
(2011)
Genes Immun
, vol.12
, pp. 399-414
-
-
Ning, S.1
Pagano, J.S.2
Barber, G.N.3
-
41
-
-
77951260924
-
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
-
doi:10.1038/ni.1863
-
Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol (2010) 11:373-84. doi:10.1038/ni.1863
-
(2010)
Nat Immunol
, vol.11
, pp. 373-384
-
-
Kawai, T.1
Akira, S.2
-
42
-
-
5444274514
-
Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6
-
doi:10.1038/ni1118
-
Kawai T, Sato S, Ishii KJ, Coban C, Hemmi H, Yamamoto M, et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol (2004) 5:1061-8. doi:10.1038/ni1118
-
(2004)
Nat Immunol
, vol.5
, pp. 1061-1068
-
-
Kawai, T.1
Sato, S.2
Ishii, K.J.3
Coban, C.4
Hemmi, H.5
Yamamoto, M.6
-
43
-
-
18644376284
-
IRF3 mediates a TLR3/TLR4-specific antiviral gene program
-
doi:10.1016/S1074-7613(02)00390-4
-
Doyle S, Vaidya S, O'Connell R, Dadgostar H, Dempsey P, Wu T, et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity (2002) 17:251-63. doi:10.1016/S1074-7613(02)00390-4
-
(2002)
Immunity
, vol.17
, pp. 251-263
-
-
Doyle, S.1
Vaidya, S.2
O'Connell, R.3
Dadgostar, H.4
Dempsey, P.5
Wu, T.6
-
44
-
-
40949134086
-
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta
-
doi:10.1038/ni1569
-
Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol (2008) 9:361-8. doi:10.1038/ni1569
-
(2008)
Nat Immunol
, vol.9
, pp. 361-368
-
-
Kagan, J.C.1
Su, T.2
Horng, T.3
Chow, A.4
Akira, S.5
Medzhitov, R.6
-
45
-
-
30544451546
-
Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6
-
doi:10.1038/nature04369
-
Häcker H, Redecke V, Blagoev B, Kratchmarova I, Hsu LC, Wang GG, et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature (2006) 439:204-7. doi:10.1038/nature04369
-
(2006)
Nature
, vol.439
, pp. 204-207
-
-
Häcker, H.1
Redecke, V.2
Blagoev, B.3
Kratchmarova, I.4
Hsu, L.C.5
Wang, G.G.6
-
46
-
-
30544447047
-
Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response
-
doi:10.1038/nature04374
-
Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature (2006) 439:208-11. doi:10.1038/nature04374
-
(2006)
Nature
, vol.439
, pp. 208-211
-
-
Oganesyan, G.1
Saha, S.K.2
Guo, B.3
He, J.Q.4
Shahangian, A.5
Zarnegar, B.6
-
47
-
-
0242624622
-
TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway
-
doi:10.1038/ni986
-
Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol (2003) 4:1144-50. doi:10.1038/ni986
-
(2003)
Nat Immunol
, vol.4
, pp. 1144-1150
-
-
Yamamoto, M.1
Sato, S.2
Hemmi, H.3
Uematsu, S.4
Hoshino, K.5
Kaisho, T.6
-
48
-
-
0033680737
-
Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction
-
doi:10.1016/S1074-7613(00)00053-4
-
Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity (2000) 13:539-48. doi:10.1016/S1074-7613(00)00053-4
-
(2000)
Immunity
, vol.13
, pp. 539-548
-
-
Sato, M.1
Suemori, H.2
Hata, N.3
Asagiri, M.4
Ogasawara, K.5
Nakao, K.6
-
49
-
-
74049136127
-
Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines
-
doi:10.1038/ni.1819
-
Tseng PH, Matsuzawa A, Zhang W, Mino T, Vignali DA, Karin M. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat Immunol (2010) 11:70-5. doi:10.1038/ni.1819
-
(2010)
Nat Immunol
, vol.11
, pp. 70-75
-
-
Tseng, P.H.1
Matsuzawa, A.2
Zhang, W.3
Mino, T.4
Vignali, D.A.5
Karin, M.6
-
50
-
-
79551686422
-
Oncogenically active MYD88 mutations in human lymphoma
-
doi:10.1038/nature09671
-
Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH, et al. Oncogenically active MYD88 mutations in human lymphoma. Nature (2011) 470:115-9. doi:10.1038/nature09671
-
(2011)
Nature
, vol.470
, pp. 115-119
-
-
Ngo, V.N.1
Young, R.M.2
Schmitz, R.3
Jhavar, S.4
Xiao, W.5
Lim, K.H.6
-
51
-
-
43549097394
-
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma
-
doi:10.1182/blood-2007-09-111948
-
Lam LT, Wright G, Davis RE, Lenz G, Farinha P, Dang L, et al. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. Blood (2008) 111:3701-13. doi:10.1182/blood-2007-09-111948
-
(2008)
Blood
, vol.111
, pp. 3701-3713
-
-
Lam, L.T.1
Wright, G.2
Davis, R.E.3
Lenz, G.4
Farinha, P.5
Dang, L.6
-
52
-
-
38949165127
-
Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas
-
doi:10.1182/blood-2007-04-087734
-
Ding BB, Yu JJ, Yu RY, Mendez LM, Shaknovich R, Zhang Y, et al. Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. Blood (2008) 111:1515-23. doi:10.1182/blood-2007-04-087734
-
(2008)
Blood
, vol.111
, pp. 1515-1523
-
-
Ding, B.B.1
Yu, J.J.2
Yu, R.Y.3
Mendez, L.M.4
Shaknovich, R.5
Zhang, Y.6
-
53
-
-
84961407275
-
Emerging targets in human lymphoma: targeting the MYD88 mutation
-
doi:10.2147/BLCTT.S35292
-
Wang JQ, Jeelall YS, Horikawa K. Emerging targets in human lymphoma: targeting the MYD88 mutation. Blood Lymphat Cancer (2013) 2013:53-61. doi:10.2147/BLCTT.S35292
-
(2013)
Blood Lymphat Cancer
, vol.2013
, pp. 53-61
-
-
Wang, J.Q.1
Jeelall, Y.S.2
Horikawa, K.3
-
54
-
-
84896814479
-
Consequences of the recurrent MYD88(L265P) somatic mutation for B cell tolerance
-
doi:10.1084/jem.20131424
-
Wang JQ, Jeelall YS, Beutler B, Horikawa K, Goodnow CC. Consequences of the recurrent MYD88(L265P) somatic mutation for B cell tolerance. J Exp Med (2014) 211:413-26. doi:10.1084/jem.20131424
-
(2014)
J Exp Med
, vol.211
, pp. 413-426
-
-
Wang, J.Q.1
Jeelall, Y.S.2
Beutler, B.3
Horikawa, K.4
Goodnow, C.C.5
-
55
-
-
84905681094
-
Oncogenic MYD88 mutants require Toll-like receptors [abstract].
-
Apr 6-10; Washington, DC. Philadelphia: AACR; Cancer Res (2013) :Abst . doi:10.1158/1538-7445.AM2013-2332
-
Lim K-H, Barton GM, Staudt LM. Oncogenic MYD88 mutants require Toll-like receptors [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia: AACR; Cancer Res (2013) 73(8 Suppl):Abst 2332. doi:10.1158/1538-7445.AM2013-2332
-
(2013)
Proceedings of the 104th Annual Meeting of the American Association for Cancer Research
, vol.73
, Issue.8 SUPPL.
, pp. 2332
-
-
Lim, K.-H.1
Barton, G.M.2
Staudt, L.M.3
-
56
-
-
79952284127
-
Hallmarks of cancer: the next generation
-
doi:10.1016/j.cell.2011.02.013
-
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell (2011) 144:646-74. doi:10.1016/j.cell.2011.02.013
-
(2011)
Cell
, vol.144
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
57
-
-
77950346282
-
Immunity, inflammation, and cancer
-
doi:10.1016/j.cell.2010.01.025
-
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell (2010) 140:883-99. doi:10.1016/j.cell.2010.01.025
-
(2010)
Cell
, vol.140
, pp. 883-899
-
-
Grivennikov, S.I.1
Greten, F.R.2
Karin, M.3
-
58
-
-
47949099098
-
Origin and physiological roles of inflammation
-
doi:10.1038/nature07201
-
Medzhitov R. Origin and physiological roles of inflammation. Nature (2008) 454:428-35. doi:10.1038/nature07201
-
(2008)
Nature
, vol.454
, pp. 428-435
-
-
Medzhitov, R.1
-
59
-
-
84965199448
-
An address on the value of pathological experiments
-
doi:10.1136/bmj.2.1075.198
-
Virchow R. An address on the value of pathological experiments. Br Med J (1881) 2:198-203. doi:10.1136/bmj.2.1075.198
-
(1881)
Br Med J
, vol.2
, pp. 198-203
-
-
Virchow, R.1
-
60
-
-
0033831517
-
Infections as a major preventable cause of human cancer
-
doi:10.1046/j.1365-2796.2000.00742.x
-
Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med (2000) 248:171-83. doi:10.1046/j.1365-2796.2000.00742.x
-
(2000)
J Intern Med
, vol.248
, pp. 171-183
-
-
Kuper, H.1
Adami, H.O.2
Trichopoulos, D.3
-
61
-
-
84892805731
-
Cancer statistics, 2014
-
doi:10.3322/caac.21208
-
Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin (2014) 64:9-29. doi:10.3322/caac.21208
-
(2014)
CA Cancer J Clin
, vol.64
, pp. 9-29
-
-
Siegel, R.1
Ma, J.2
Zou, Z.3
Jemal, A.4
-
62
-
-
33745298519
-
Nuclear factor-kappaB in cancer development and progression
-
doi:10.1038/nature04870
-
Karin M. Nuclear factor-kappaB in cancer development and progression. Nature (2006) 441:431-6. doi:10.1038/nature04870
-
(2006)
Nature
, vol.441
, pp. 431-436
-
-
Karin, M.1
-
63
-
-
69949120571
-
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses
-
doi:10.1038/nm.2015
-
Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med (2009) 15:1016-22. doi:10.1038/nm.2015
-
(2009)
Nat Med
, vol.15
, pp. 1016-1022
-
-
Wu, S.1
Rhee, K.J.2
Albesiano, E.3
Rabizadeh, S.4
Wu, X.5
Yen, H.R.6
-
64
-
-
0037180757
-
Inflammation and cancer
-
doi:10.1038/nature01322
-
Coussens LM, Werb Z. Inflammation and cancer. Nature (2002) 420:860-7. doi:10.1038/nature01322
-
(2002)
Nature
, vol.420
, pp. 860-867
-
-
Coussens, L.M.1
Werb, Z.2
-
65
-
-
67649660551
-
Redefining chronic viral infection
-
doi:10.1016/j.cell.2009.06.036
-
Virgin HW, Wherry EJ, Ahmed R. Redefining chronic viral infection. Cell (2009) 138:30-50. doi:10.1016/j.cell.2009.06.036
-
(2009)
Cell
, vol.138
, pp. 30-50
-
-
Virgin, H.W.1
Wherry, E.J.2
Ahmed, R.3
-
66
-
-
30144443269
-
Paradoxical roles of the immune system during cancer development
-
doi:10.1038/nrc1782
-
de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer (2006) 6:24-37. doi:10.1038/nrc1782
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 24-37
-
-
De Visser, K.E.1
Eichten, A.2
Coussens, L.M.3
-
67
-
-
33847650413
-
Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?
-
doi:10.1016/j.coi.2007.02.001
-
Bui JD, Schreiber RD. Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? Curr Opin Immunol (2007) 19:203-8. doi:10.1016/j.coi.2007.02.001
-
(2007)
Curr Opin Immunol
, vol.19
, pp. 203-208
-
-
Bui, J.D.1
Schreiber, R.D.2
-
68
-
-
38649087921
-
Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis
-
doi:10.1073/pnas.0708594105
-
Swann JB, Vesely MD, Silva A, Sharkey J, Akira S, Schreiber RD, et al. Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc Natl Acad Sci U S A (2008) 105:652-6. doi:10.1073/pnas.0708594105
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 652-656
-
-
Swann, J.B.1
Vesely, M.D.2
Silva, A.3
Sharkey, J.4
Akira, S.5
Schreiber, R.D.6
-
69
-
-
34248141100
-
A cytokine-mediated link between innate immunity, inflammation, and cancer
-
doi:10.1172/JCI31537
-
Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest (2007) 117:1175-83. doi:10.1172/JCI31537
-
(2007)
J Clin Invest
, vol.117
, pp. 1175-1183
-
-
Lin, W.W.1
Karin, M.2
-
70
-
-
33646755569
-
Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity
-
doi:10.1016/S0065-2776(06)90001-7
-
Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol (2006) 90:1-50. doi:10.1016/S0065-2776(06)90001-7
-
(2006)
Adv Immunol
, vol.90
, pp. 1-50
-
-
Smyth, M.J.1
Dunn, G.P.2
Schreiber, R.D.3
-
71
-
-
79956300649
-
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
-
doi:10.1016/j.immuni.2011.05.006
-
Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity (2011) 34:637-50. doi:10.1016/j.immuni.2011.05.006
-
(2011)
Immunity
, vol.34
, pp. 637-650
-
-
Kawai, T.1
Akira, S.2
-
72
-
-
33845865825
-
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
-
doi:10.1038/nri1995
-
Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol (2007) 7:41-51. doi:10.1038/nri1995
-
(2007)
Nat Rev Immunol
, vol.7
, pp. 41-51
-
-
Yu, H.1
Kortylewski, M.2
Pardoll, D.3
-
73
-
-
67650151005
-
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
-
doi:10.1093/carcin/bgp127
-
Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis (2009) 30:1073-81. doi:10.1093/carcin/bgp127
-
(2009)
Carcinogenesis
, vol.30
, pp. 1073-1081
-
-
Colotta, F.1
Allavena, P.2
Sica, A.3
Garlanda, C.4
Mantovani, A.5
-
74
-
-
34249782578
-
Role of AID in tumorigenesis
-
doi:10.1016/S0065-2776(06)94008-5
-
Okazaki IM, Kotani A, Honjo T. Role of AID in tumorigenesis. Adv Immunol (2007) 94:245-73. doi:10.1016/S0065-2776(06)94008-5
-
(2007)
Adv Immunol
, vol.94
, pp. 245-273
-
-
Okazaki, I.M.1
Kotani, A.2
Honjo, T.3
-
75
-
-
39149099085
-
Two levels of protection for the B cell genome during somatic hypermutation
-
doi:10.1038/nature06547
-
Liu M, Duke JL, Richter DJ, Vinuesa CG, Goodnow CC, Kleinstein SH, et al. Two levels of protection for the B cell genome during somatic hypermutation. Nature (2008) 451:841-5. doi:10.1038/nature06547
-
(2008)
Nature
, vol.451
, pp. 841-845
-
-
Liu, M.1
Duke, J.L.2
Richter, D.J.3
Vinuesa, C.G.4
Goodnow, C.C.5
Kleinstein, S.H.6
-
76
-
-
33644643189
-
Role of genomic instability and p53 in AID-induced c-myc-Igh translocations
-
doi:10.1038/nature04495
-
Ramiro AR, Jankovic M, Callen E, Difilippantonio S, Chen HT, McBride KM, et al. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature (2006) 440:105-9. doi:10.1038/nature04495
-
(2006)
Nature
, vol.440
, pp. 105-109
-
-
Ramiro, A.R.1
Jankovic, M.2
Callen, E.3
Difilippantonio, S.4
Chen, H.T.5
McBride, K.M.6
-
77
-
-
0020621665
-
Malignant lymphoma of mucosa-associated lymphoid tissue
-
doi:10.1002/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3
-
Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer (1983) 52:1410-6. doi:10.1002/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3
-
(1983)
A distinctive type of B-cell lymphoma. Cancer
, vol.52
, pp. 1410-1416
-
-
Isaacson, P.1
Wright, D.H.2
-
78
-
-
61849140711
-
Infectious agents and lymphoma development: molecular and clinical aspects
-
doi:10.1111/j.1365-2796.2009.02083.x
-
Ferreri AJ, Ernberg I, Copie-Bergman C. Infectious agents and lymphoma development: molecular and clinical aspects. J Intern Med (2009) 265:421-38. doi:10.1111/j.1365-2796.2009.02083.x
-
(2009)
J Intern Med
, vol.265
, pp. 421-438
-
-
Ferreri, A.J.1
Ernberg, I.2
Copie-Bergman, C.3
-
79
-
-
33846644490
-
Transcriptional profiling suggests that secondary and primary large B-cell lymphomas of the gastrointestinal (GI) tract are blastic variants of GI marginal zone lymphoma
-
doi:10.1002/path.2096
-
Barth TF, Barth CA, Kestler HA, Michl P, Weniger MA, Buchholz M, et al. Transcriptional profiling suggests that secondary and primary large B-cell lymphomas of the gastrointestinal (GI) tract are blastic variants of GI marginal zone lymphoma. J Pathol (2007) 211:305-13. doi:10.1002/path.2096
-
(2007)
J Pathol
, vol.211
, pp. 305-313
-
-
Barth, T.F.1
Barth, C.A.2
Kestler, H.A.3
Michl, P.4
Weniger, M.A.5
Buchholz, M.6
-
80
-
-
0034977290
-
Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells
-
doi:10.1128/IAI.69.7.4382-4389.2001
-
Kawahara T, Teshima S, Oka A, Sugiyama T, Kishi K, Rokutan K. Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect Immun (2001) 69:4382-9. doi:10.1128/IAI.69.7.4382-4389.2001
-
(2001)
Infect Immun
, vol.69
, pp. 4382-4389
-
-
Kawahara, T.1
Teshima, S.2
Oka, A.3
Sugiyama, T.4
Kishi, K.5
Rokutan, K.6
-
81
-
-
3242733824
-
Leaky catecholamine stores: undue waste or a stress response coping mechanism?
-
doi:10.1196/annals.1296.027
-
Eisenhofer G, Kopin IJ, Goldstein DS. Leaky catecholamine stores: undue waste or a stress response coping mechanism? Ann N Y Acad Sci (2004) 1018:224-30. doi:10.1196/annals.1296.027
-
(2004)
Ann N Y Acad Sci
, vol.1018
, pp. 224-230
-
-
Eisenhofer, G.1
Kopin, I.J.2
Goldstein, D.S.3
-
82
-
-
20144373185
-
Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori
-
doi:10.1016/j.ijmm.2005.02.009
-
Schmausser B, Andrulis M, Endrich S, Muller-Hermelink HK, Eck M. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol (2005) 295:179-85. doi:10.1016/j.ijmm.2005.02.009
-
(2005)
Int J Med Microbiol
, vol.295
, pp. 179-185
-
-
Schmausser, B.1
Andrulis, M.2
Endrich, S.3
Muller-Hermelink, H.K.4
Eck, M.5
-
83
-
-
37849033136
-
Role of Toll-like receptors in gastrointestinal malignancies
-
doi:10.1038/sj.onc.1210908
-
Fukata M, Abreu MT. Role of Toll-like receptors in gastrointestinal malignancies. Oncogene (2008) 27:234-43. doi:10.1038/sj.onc.1210908
-
(2008)
Oncogene
, vol.27
, pp. 234-243
-
-
Fukata, M.1
Abreu, M.T.2
-
84
-
-
27244433609
-
Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma
-
doi:10.1200/JCO.2005.05.011
-
Farinha P, Gascoyne RD. Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J Clin Oncol (2005) 23:6370-8. doi:10.1200/JCO.2005.05.011
-
(2005)
J Clin Oncol
, vol.23
, pp. 6370-6378
-
-
Farinha, P.1
Gascoyne, R.D.2
-
85
-
-
0033756964
-
Role of activated host T cells in the promotion of MALT lymphoma growth
-
doi:10.1006/scbi.2000.0351
-
Guindi M. Role of activated host T cells in the promotion of MALT lymphoma growth. Semin Cancer Biol (2000) 10:341-4. doi:10.1006/scbi.2000.0351
-
(2000)
Semin Cancer Biol
, vol.10
, pp. 341-344
-
-
Guindi, M.1
-
86
-
-
77953556367
-
Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development
-
doi:10.1038/nrgastro.2010.58
-
Sagaert X, Van Cutsem E, De Hertogh G, Geboes K, Tousseyn T. Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development. Nat Rev Gastroenterol Hepatol (2010) 7:336-46. doi:10.1038/nrgastro.2010.58
-
(2010)
Nat Rev Gastroenterol Hepatol
, vol.7
, pp. 336-346
-
-
Sagaert, X.1
Van Cutsem, E.2
De Hertogh, G.3
Geboes, K.4
Tousseyn, T.5
-
87
-
-
77449108587
-
Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins
-
doi:10.1182/blood-2009-06-228015
-
Craig VJ, Arnold I, Gerke C, Huynh MQ, Wündisch T, Neubauer A, et al. Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood (2010) 115:581-91. doi:10.1182/blood-2009-06-228015
-
(2010)
Blood
, vol.115
, pp. 581-591
-
-
Craig, V.J.1
Arnold, I.2
Gerke, C.3
Huynh, M.Q.4
Wündisch, T.5
Neubauer, A.6
-
88
-
-
33846454674
-
Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?
-
doi:10.1111/j.1365-2141.2006.06444.x
-
Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? Br J Haematol (2007) 136:521-38. doi:10.1111/j.1365-2141.2006.06444.x
-
(2007)
Br J Haematol
, vol.136
, pp. 521-538
-
-
Ferrucci, P.F.1
Zucca, E.2
-
89
-
-
68449095767
-
Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis
-
doi:10.1038/ajg.2009.314
-
Zullo A, Hassan C, Andriani A, Cristofari F, De FrancescoV, Ierardi E, et al. Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis. Am J Gastroenterol (2009) 104:1932-1937;quiz1938. doi:10.1038/ajg.2009.314
-
(2009)
Am J Gastroenterol
, vol.104
-
-
Zullo, A.1
Hassan, C.2
Andriani, A.3
Cristofari, F.4
De, FrancescoV.5
Ierardi, E.6
-
90
-
-
13844307760
-
Chronic lymphocytic leukemia
-
doi:10.1056/NEJMra041720
-
Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med (2005) 352:804-15. doi:10.1056/NEJMra041720
-
(2005)
N Engl J Med
, vol.352
, pp. 804-815
-
-
Chiorazzi, N.1
Rai, K.R.2
Ferrarini, M.3
-
91
-
-
73349098730
-
Chronic lymphocytic leukemia of Emu-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression
-
doi:10.1182/blood-2009-06-230169
-
Enzler T, Kater AP, Zhang W, Widhopf GF2nd, Chuang HY, Lee J, et al. Chronic lymphocytic leukemia of Emu-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression. Blood (2009) 114:4469-76. doi:10.1182/blood-2009-06-230169
-
(2009)
Blood
, vol.114
, pp. 4469-4476
-
-
Enzler, T.1
Kater, A.P.2
Zhang, W.3
Widhopf II, G.F.4
Chuang, H.Y.5
Lee, J.6
-
92
-
-
0035353212
-
Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia
-
doi:10.1182/blood.V97.9.2777
-
Granziero L, Ghia P, Circosta P, Gottardi D, Strola G, Geuna M, et al. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood (2001) 97:2777-83. doi:10.1182/blood.V97.9.2777
-
(2001)
Blood
, vol.97
, pp. 2777-2783
-
-
Granziero, L.1
Ghia, P.2
Circosta, P.3
Gottardi, D.4
Strola, G.5
Geuna, M.6
-
93
-
-
0036720390
-
Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1.
-
Pedersen IM, Kitada S, Leoni LM, Zapata JM, Karras JG, Tsukada N, et al. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood (2002) 100:1795-801.
-
(2002)
Blood
, vol.100
, pp. 1795-1801
-
-
Pedersen, I.M.1
Kitada, S.2
Leoni, L.M.3
Zapata, J.M.4
Karras, J.G.5
Tsukada, N.6
-
94
-
-
0032168152
-
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
-
Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J (1998) 334(Pt 2):297-314.
-
(1998)
Biochem J
, vol.334
, Issue.PART 2
, pp. 297-314
-
-
Heinrich, P.C.1
Behrmann, I.2
Muller-Newen, G.3
Schaper, F.4
Graeve, L.5
-
95
-
-
0027199126
-
IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase
-
doi:10.1126/science.8511589
-
Murakami M, Hibi M, Nakagawa N, Nakagawa T, Yasukawa K, Yamanishi K, et al. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science (1993) 260:1808-10. doi:10.1126/science.8511589
-
(1993)
Science
, vol.260
, pp. 1808-1810
-
-
Murakami, M.1
Hibi, M.2
Nakagawa, N.3
Nakagawa, T.4
Yasukawa, K.5
Yamanishi, K.6
-
96
-
-
39649113108
-
Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival
-
doi:10.1002/ijc.23261
-
Wegiel B, Bjartell A, Culig Z, Persson JL. Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival. Int J Cancer (2008) 122:1521-9. doi:10.1002/ijc.23261
-
(2008)
Int J Cancer
, vol.122
, pp. 1521-1529
-
-
Wegiel, B.1
Bjartell, A.2
Culig, Z.3
Persson, J.L.4
-
97
-
-
77951018948
-
STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells
-
doi:10.1182/blood-2009-10-230060
-
Hazan-Halevy I, Harris D, Liu Z, Liu J, Li P, Chen X, et al. STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells. Blood (2010) 115:2852-63. doi:10.1182/blood-2009-10-230060
-
(2010)
Blood
, vol.115
, pp. 2852-2863
-
-
Hazan-Halevy, I.1
Harris, D.2
Liu, Z.3
Liu, J.4
Li, P.5
Chen, X.6
-
98
-
-
0031436969
-
B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues
-
doi:10.1172/JCI119869
-
Frank DA, Mahajan S, Ritz J. B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues. J Clin Invest (1997) 100:3140-8. doi:10.1172/JCI119869
-
(1997)
J Clin Invest
, vol.100
, pp. 3140-3148
-
-
Frank, D.A.1
Mahajan, S.2
Ritz, J.3
-
99
-
-
64749113465
-
Treatment of relapsed/refractory multiple myeloma
-
doi:10.1053/j.seminhematol.2009.01.004
-
Kastritis E, Palumbo A, Dimopoulos MA. Treatment of relapsed/refractory multiple myeloma. Semin Hematol (2009) 46:143-57. doi:10.1053/j.seminhematol.2009.01.004
-
(2009)
Semin Hematol
, vol.46
, pp. 143-157
-
-
Kastritis, E.1
Palumbo, A.2
Dimopoulos, M.A.3
-
100
-
-
27544476971
-
The role of IL-6 and STAT3 in inflammation and cancer
-
doi:10.1016/j.ejca.2005.08.016
-
Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer (2005) 41:2502-12. doi:10.1016/j.ejca.2005.08.016
-
(2005)
Eur J Cancer
, vol.41
, pp. 2502-2512
-
-
Hodge, D.R.1
Hurt, E.M.2
Farrar, W.L.3
-
101
-
-
0035072851
-
Mouse plasmacytoma: an experimental model of human multiple myeloma.
-
Gadó K, Silva S, Pálóczi K, Domján G, Falus A. Mouse plasmacytoma: an experimental model of human multiple myeloma. Haematologica (2001) 86:227-36.
-
(2001)
Haematologica
, vol.86
, pp. 227-236
-
-
Gadó, K.1
Silva, S.2
Pálóczi, K.3
Domján, G.4
Falus, A.5
-
102
-
-
84879849025
-
A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease
-
doi:10.1158/1078-0432.CCR-12-3349
-
Kurzrock R, Voorhees PM, Casper C, Furman RR, Fayad L, Lonial S, et al. A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease. Clin Cancer Res (2013) 19:3659-70. doi:10.1158/1078-0432.CCR-12-3349
-
(2013)
Clin Cancer Res
, vol.19
, pp. 3659-3670
-
-
Kurzrock, R.1
Voorhees, P.M.2
Casper, C.3
Furman, R.R.4
Fayad, L.5
Lonial, S.6
-
103
-
-
84876196796
-
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma
-
doi:10.1111/bjh.12266
-
Voorhees PM, Manges RF, Sonneveld P, Jagannath S, Somlo G, Krishnan A, et al. A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma. Br J Haematol (2013) 161:357-66. doi:10.1111/bjh.12266
-
(2013)
Br J Haematol
, vol.161
, pp. 357-366
-
-
Voorhees, P.M.1
Manges, R.F.2
Sonneveld, P.3
Jagannath, S.4
Somlo, G.5
Krishnan, A.6
-
104
-
-
0036720519
-
Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia
-
doi:10.1002/cncr.10772
-
Lai R, O'Brien S, Maushouri T, Rogers A, Kantarjian H, Keating M, et al. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia. Cancer (2002) 95:1071-5. doi:10.1002/cncr.10772
-
(2002)
Cancer
, vol.95
, pp. 1071-1075
-
-
Lai, R.1
O'Brien, S.2
Maushouri, T.3
Rogers, A.4
Kantarjian, H.5
Keating, M.6
-
105
-
-
0032524335
-
MyD88, an adapter protein involved in interleukin-1 signaling
-
doi:10.1074/jbc.273.20.12203
-
Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer JL, et al. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem (1998) 273:12203-9. doi:10.1074/jbc.273.20.12203
-
(1998)
J Biol Chem
, vol.273
, pp. 12203-12209
-
-
Burns, K.1
Martinon, F.2
Esslinger, C.3
Pahl, H.4
Schneider, P.5
Bodmer, J.L.6
-
106
-
-
18144362027
-
Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-{kappa}B
-
doi:10.1074/jbc.C400613200
-
Loiarro M, Sette C, Gallo G, Ciacci A, Fantò N, Mastroianni D, et al. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-{kappa}B. J Biol Chem (2005) 280:15809-14. doi:10.1074/jbc.C400613200
-
(2005)
J Biol Chem
, vol.280
, pp. 15809-15814
-
-
Loiarro, M.1
Sette, C.2
Gallo, G.3
Ciacci, A.4
Fantò, N.5
Mastroianni, D.6
-
107
-
-
34548415806
-
Pivotal advance: inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound
-
doi:10.1189/jlb.1206746
-
Loiarro M, Capolunghi F, Fantò N, Gallo G, Campo S, Arseni B, et al. Pivotal advance: inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound. J Leukoc Biol (2007) 82:801-10. doi:10.1189/jlb.1206746
-
(2007)
J Leukoc Biol
, vol.82
, pp. 801-810
-
-
Loiarro, M.1
Capolunghi, F.2
Fantò, N.3
Gallo, G.4
Campo, S.5
Arseni, B.6
-
108
-
-
0037596457
-
A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses
-
doi:10.1073/pnas.0932746100
-
Bartfai T, Behrens MM, Gaidarova S, Pemberton J, Shivanyuk A, Rebek JJr. A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses. Proc Natl Acad Sci U S A (2003) 100:7971-6. doi:10.1073/pnas.0932746100
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 7971-7976
-
-
Bartfai, T.1
Behrens, M.M.2
Gaidarova, S.3
Pemberton, J.4
Shivanyuk, A.5
Rebek Jr., J.6
-
109
-
-
43949131788
-
Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells
-
doi:10.1002/ijc.23477
-
Mackenzie GG, Queisser N, Wolfson ML, Fraga CG, Adamo AM, Oteiza PI. Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells. Int J Cancer (2008) 123:56-65. doi:10.1002/ijc.23477
-
(2008)
Int J Cancer
, vol.123
, pp. 56-65
-
-
Mackenzie, G.G.1
Queisser, N.2
Wolfson, M.L.3
Fraga, C.G.4
Adamo, A.M.5
Oteiza, P.I.6
-
110
-
-
70349322986
-
STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma
-
doi:10.1038/leu.2009.91
-
Coppo P, Gouilleux-Gruart V, Huang Y, Bouhlal H, Bouamar H, Bouchet S, et al. STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma. Leukemia (2009) 23:1667-78. doi:10.1038/leu.2009.91
-
(2009)
Leukemia
, vol.23
, pp. 1667-1678
-
-
Coppo, P.1
Gouilleux-Gruart, V.2
Huang, Y.3
Bouhlal, H.4
Bouamar, H.5
Bouchet, S.6
-
111
-
-
34548225362
-
NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta
-
doi:10.1016/j.cell.2007.07.009
-
Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C, et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell (2007) 130:918-31. doi:10.1016/j.cell.2007.07.009
-
(2007)
Cell
, vol.130
, pp. 918-931
-
-
Greten, F.R.1
Arkan, M.C.2
Bollrath, J.3
Hsu, L.C.4
Goode, J.5
Miething, C.6
-
112
-
-
78650859531
-
NF-kappaB and STAT3 - key players in liver inflammation and cancer
-
doi:10.1038/cr.2010.183
-
He G, Karin M. NF-kappaB and STAT3 - key players in liver inflammation and cancer. Cell Res (2011) 21:159-68. doi:10.1038/cr.2010.183
-
(2011)
Cell Res
, vol.21
, pp. 159-168
-
-
He, G.1
Karin, M.2
-
113
-
-
28644445445
-
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
-
doi:10.1038/nm1325
-
Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, Pilon-Thomas S, et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med (2005) 11:1314-21. doi:10.1038/nm1325
-
(2005)
Nat Med
, vol.11
, pp. 1314-1321
-
-
Kortylewski, M.1
Kujawski, M.2
Wang, T.3
Wei, S.4
Zhang, S.5
Pilon-Thomas, S.6
-
114
-
-
70350500225
-
STATs in cancer inflammation and immunity: a leading role for STAT3
-
doi:10.1038/nrc2734
-
Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer (2009) 9:798-809. doi:10.1038/nrc2734
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 798-809
-
-
Yu, H.1
Pardoll, D.2
Jove, R.3
-
115
-
-
70949094349
-
The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors
-
doi:10.1016/j.ccr.2009.10.015
-
Hedvat M, Huszar D, Herrmann A, Gozgit JM, Schroeder A, Sheehy A, et al. The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors. Cancer Cell (2009) 16:487-97. doi:10.1016/j.ccr.2009.10.015
-
(2009)
Cancer Cell
, vol.16
, pp. 487-497
-
-
Hedvat, M.1
Huszar, D.2
Herrmann, A.3
Gozgit, J.M.4
Schroeder, A.5
Sheehy, A.6
-
116
-
-
60549108333
-
The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling
-
doi:10.1038/onc.2008.448
-
Lin L, Amin R, Gallicano GI, Glasgow E, Jogunoori W, Jessup JM, et al. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling. Oncogene (2009) 28:961-72. doi:10.1038/onc.2008.448
-
(2009)
Oncogene
, vol.28
, pp. 961-972
-
-
Lin, L.1
Amin, R.2
Gallicano, G.I.3
Glasgow, E.4
Jogunoori, W.5
Jessup, J.M.6
-
117
-
-
0036895749
-
TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells
-
doi:10.1053/jhep.2002.36942
-
Kim YS, Schwabe RF, Qian T, Lemasters JJ, Brenner DA. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells. Hepatology (2002) 36:1498-508. doi:10.1053/jhep.2002.36942
-
(2002)
Hepatology
, vol.36
, pp. 1498-1508
-
-
Kim, Y.S.1
Schwabe, R.F.2
Qian, T.3
Lemasters, J.J.4
Brenner, D.A.5
-
118
-
-
33750586523
-
Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells
-
doi:10.1158/1541-7786.MCR-05-0231
-
Braeuer SJ, Buneker C, Mohr A, Zwacka RM. Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells. Mol Cancer Res (2006) 4:715-28. doi:10.1158/1541-7786.MCR-05-0231
-
(2006)
Mol Cancer Res
, vol.4
, pp. 715-728
-
-
Braeuer, S.J.1
Buneker, C.2
Mohr, A.3
Zwacka, R.M.4
-
119
-
-
84862152044
-
Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma
-
doi:10.1016/j.ccr.2012.05.024
-
Yang Y, Shaffer AL3rd, Emre NC, Ceribelli M, Zhang M, Wright G, et al. Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. Cancer Cell (2012) 21:723-37. doi:10.1016/j.ccr.2012.05.024
-
(2012)
Cancer Cell
, vol.21
, pp. 723-737
-
-
Yang, Y.1
Shaffer III, A.L.2
Emre, N.C.3
Ceribelli, M.4
Zhang, M.5
Wright, G.6
-
120
-
-
17144404177
-
IRF-7 is the master regulator of type-I interferon-dependent immune responses
-
doi:10.1038/nature03464
-
Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature (2005) 434:772-7. doi:10.1038/nature03464
-
(2005)
Nature
, vol.434
, pp. 772-777
-
-
Honda, K.1
Yanai, H.2
Negishi, H.3
Asagiri, M.4
Sato, M.5
Mizutani, T.6
-
121
-
-
77954662424
-
Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells
-
doi:10.1182/blood-2009-03-213363
-
Liang X, Moseman EA, Farrar MA, Bachanova V, Weisdorf DJ, Blazar BR, et al. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells. Blood (2010) 115:5041-52. doi:10.1182/blood-2009-03-213363
-
(2010)
Blood
, vol.115
, pp. 5041-5052
-
-
Liang, X.1
Moseman, E.A.2
Farrar, M.A.3
Bachanova, V.4
Weisdorf, D.J.5
Blazar, B.R.6
-
122
-
-
84877262630
-
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy
-
doi:10.4161/onci.20931
-
Vacchelli E, Galluzzi L, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, et al. Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy. Oncoimmunology (2012) 1:894-907. doi:10.4161/onci.20931
-
(2012)
Oncoimmunology
, vol.1
, pp. 894-907
-
-
Vacchelli, E.1
Galluzzi, L.2
Eggermont, A.3
Fridman, W.H.4
Galon, J.5
Sautès-Fridman, C.6
-
123
-
-
84872801225
-
Trial watch: experimental Toll-like receptor agonists for cancer therapy
-
doi:10.4161/onci.20696
-
Galluzzi L, Vacchelli E, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, et al. Trial watch: experimental Toll-like receptor agonists for cancer therapy. Oncoimmunology (2012) 1:699-716. doi:10.4161/onci.20696
-
(2012)
Oncoimmunology
, vol.1
, pp. 699-716
-
-
Galluzzi, L.1
Vacchelli, E.2
Eggermont, A.3
Fridman, W.H.4
Galon, J.5
Sautès-Fridman, C.6
-
124
-
-
77953469710
-
Toll-like receptor agonists in cancer therapy
-
doi:10.2217/imt.09.70
-
Adams S. Toll-like receptor agonists in cancer therapy. Immunotherapy (2009) 1:949-64. doi:10.2217/imt.09.70
-
(2009)
Immunotherapy
, vol.1
, pp. 949-964
-
-
Adams, S.1
-
125
-
-
84902598355
-
Mutations in the Toll-like receptor/MYD88 pathway in chronic lymphocytic leukemia identify a subset of young patients with favorable outcome
-
doi:10.1182/blood-2013-12-543306
-
Martínez-Trillos A, Pinyol M, Navarro A, Aymerich M, Jares P, Juan M, et al. Mutations in the Toll-like receptor/MYD88 pathway in chronic lymphocytic leukemia identify a subset of young patients with favorable outcome. Blood (2014) 123:3790-6. doi:10.1182/blood-2013-12-543306
-
(2014)
Blood
, vol.123
, pp. 3790-3796
-
-
Martínez-Trillos, A.1
Pinyol, M.2
Navarro, A.3
Aymerich, M.4
Jares, P.5
Juan, M.6
|